Drug Profile
Brimonidine topical gel - Galderma
Alternative Names: Brimonidine tartrate gel; CD 07805/47; COL 118; Col-118; Mirvaso; Onreltea; Sansrosa; SR-101Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator SansRosa Pharmaceutical Development
- Developer Galderma
- Class Antiglaucomas; Antihypertensives; Bromobenzenes; Diamines; Eye disorder therapies; Imidazoles; Quinoxalines; Skin disorder therapies; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Erythema
Most Recent Events
- 03 Jun 2020 Launched for Erythema in Russia (Topical) before June 2020
- 09 Aug 2019 No development reported - Phase-II for Erythema (Prevention) in Germany (Topical)
- 09 Aug 2019 No development reported - Phase-III for Erythema in Russia (Topical)